Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Jason P. Rhodes | Director | Grant, award, or other acquisition of securities at price $ 13.50 per share. | 27 Jan 2025 | 1,111,111 | 1,958,427 | - | 13.5 | 14,999,999 | Common Stock |
| Rithm Cap Corp | Michael Nierenberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 886,359 | 886,359 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Stem Inc (Class A) | Arun Narayanan | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 750,000 | 750,000 | - | - | Restricted Stock Unit | |
| Joby Aviation Inc | Nicholas Kalayjian | Chief Hardware Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 620,067 | 620,067 | - | - | Restricted Stock Units (RSUs) | |
| Milestone Pharma Inc | Joseph G. Oliveto | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 399,600 | 399,600 | - | - | Employee Stock Option (right to buy) | |
| WisdomTree Inc | Jonathan L. Steinberg | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 387,336 | 0 | - | - | Performance Based Restricted Stock Units | |
| WisdomTree Inc | Jonathan L. Steinberg | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 387,336 | 9,681,406 (6%) | 0% | 0 | Common Stock | |
| Milestone Pharma Inc | Joseph G. Oliveto | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 266,400 | 266,400 | - | - | Restricted Stock Unit | |
| DHI Grp Inc | Art Zeile | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 250,000 | 3,341,092 (6%) | 0% | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Mary T. Szela | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 240,000 | 240,000 | - | - | Employee Stock Option (right to buy) | |
| Exlservice Hldgs Inc | Rohit Kapoor | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 226,470 | 867,105 (2%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Stem Inc (Class A) | Arun Narayanan | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 225,000 | 225,000 | - | - | Restricted Stock Unit | |
| Compass Inc (Class A) | Scott Wahlers | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 199,744 | 199,744 | - | - | Restricted Stock Unit (RSU) | |
| Texas Instruments | Haviv Ilan | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 199,671 | 199,671 | - | - | NQ Stock Option (Right to Buy) | |
| WisdomTree Inc | Jonathan L. Steinberg | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Jan 2025 | 198,415 | 9,482,991 (6%) | 0% | 0 | Common Stock | |
| Coupang Inc (Class A) | Harold Rogers | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 177,982 | 619,940 | - | 0 | Class A Common Stock | |
| WisdomTree Inc | R. Jarrett | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 157,526 | 0 | - | - | Performance Based Restricted Stock Units | |
| WisdomTree Inc | R. Jarrett | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 157,526 | 1,154,779 (0%) | 0% | 0 | Common Stock | |
| Exlservice Hldgs Inc | Rohit Kapoor | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 150,990 | 640,635 (1%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Neurocrine Biosciences Inc | Kevin C. Gorman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.99 per share. | 27 Jan 2025 | 146,105 | 660,701 (0%) | 0% | 33.0 | 4,820,004 | Common Stock |
| Neurocrine Biosciences Inc | Kevin C. Gorman | Director | Sale of securities on an exchange or to another person at price $ 149.46 per share. | 27 Jan 2025 | 146,105 | 514,596 (0%) | 0% | 149.5 | 21,836,503 | Common Stock |
| Neurocrine Biosciences Inc | Kevin C. Gorman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 146,105 | 0 | - | - | Non-Qualified Stock Option | |
| Franklin BSP Realty Trust Inc | Michael Comparato | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 136,882 | 494,727 | - | 0 | Common Stock | |
| H.B. Fuller Co | Celeste Beeks Mastin | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 135,135 | 135,135 | - | - | Employee Stock Option (Right-to-Buy) | |
| Ironwood Pharma Inc (Class A) | Ronald Silver | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 133,333 | 291,703 (0%) | 0% | 0 | Class A Common Stock | |
| OnKure Therapeutics Inc (Class A) | Nicholas A. Saccomano | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 130,000 | 130,000 | - | - | Employee Stock Option (right to buy) | |
| Processa Pharma Inc | David Young | Director, Pres. Research & Development | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 27 Jan 2025 | 124,500 | 205,405 | - | 0.8 | 99,289 | Common Stock |
| Processa Pharma Inc | David Young | Director, Pres. Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 124,500 | 124,500 | - | - | Warrants | |
| Milestone Pharma Inc | Lorenz Muller | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 120,600 | 120,600 | - | - | Employee Stock Option (right to buy) | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 120,600 | 120,600 | - | - | Employee Stock Option (right to buy) | |
| Milestone Pharma Inc | David Bharucha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 120,600 | 120,600 | - | - | Employee Stock Option (right to buy) | |
| Milestone Pharma Inc | Jeffrey Edward Nelson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 120,600 | 120,600 | - | - | Employee Stock Option (right to buy) | |
| Ironwood Pharma Inc (Class A) | Gregory S. Martini | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 111,111 | 195,862 (0%) | 0% | 0 | Class A Common Stock | |
| Franklin BSP Realty Trust Inc | Richard J. Byrne | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 106,969 | 490,066 | - | 0 | Common Stock | |
| NewAmsterdam Pharma Co NV | Douglas F. Kling | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 104,174 | 321,971 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Douglas F. Kling | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 104,174 | 148,174 | - | - | Ordinary Shares | |
| Alset Inc | Fai Heng Chan | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.93 per share. | 27 Jan 2025 | 100,000 | 6,038,438 | - | 0.9 | 93,000 | Common Stock |
| Merck & Company | Robert M. Davis | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 95,275 | 443,601 (0%) | 0% | 97.9 | 9,331,234 | Common Stock |
| Franklin BSP Realty Trust Inc | Jerome S. Baglien | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 91,255 | 260,221 | - | 0 | Common Stock | |
| Full House Resorts Inc | Lewis A. Fanger | Director, Sr. VP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 90,524 | 0 | - | - | Employee Stock Option (right to buy) | |
| Full House Resorts Inc | Lewis A. Fanger | Director, Sr. VP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.37 per share. | 27 Jan 2025 | 90,524 | 345,182 (1%) | 0% | 1.4 | 124,018 | Common Stock |
| Grindr Inc (Class A) | J. Michael Gearon | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Jan 2025 | 84,964 | 0 | - | - | Warrants | |
| Texas Instruments | Richard K. Templeton | Director, Chairman | 27 Jan 2025 | 83,197 | 83,197 | - | - | NQ Stock Option (Right to Buy) | ||
| WisdomTree Inc | R. Jarrett | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Jan 2025 | 81,141 | 1,073,638 (0%) | 0% | 0 | Common Stock | |
| Milestone Pharma Inc | Lorenz Muller | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 80,400 | 80,400 | - | - | Restricted Stock Unit | |
| Milestone Pharma Inc | Amit Hasija | CFO & EVP of Corp. Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 80,400 | 80,400 | - | - | Restricted Stock Unit | |
| Milestone Pharma Inc | David Bharucha | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 80,400 | 80,400 | - | - | Restricted Stock Unit | |
| Milestone Pharma Inc | Jeffrey Edward Nelson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 80,400 | 80,400 | - | - | Restricted Stock Unit | |
| NewAmsterdam Pharma Co NV | Douglas F. Kling | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Jan 2025 | 80,359 | 67,815 | - | - | Ordinary Shares | |
| DHI Grp Inc | Paul Farnsworth | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 80,000 | 646,796 (1%) | 0% | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Sean E. Murphy | Director, Chief Manuf, Strategy&Bus Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | James Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Photronics Inc | George C. Macricostas | EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 70,000 | 168,000 (0%) | 0% | 0 | COMMON STOCK | |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Jan 2025 | 66,413 | 66,413 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Jan 2025 | 66,413 | 31,097,792 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Jan 2025 | 66,413 | 66,413 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Jan 2025 | 66,413 | 31,097,792 | - | - | Class B Common Stock | ||
| OnKure Therapeutics Inc (Class A) | Jason A. Leverone | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 65,000 | 65,000 | - | - | Employee Stock Option (right to buy) | |
| Hexcel Corp | Thomas C. Gentile | Director, Chairman, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 64,145 | 64,145 | - | - | Non-Qualified Stock Options | |
| TriSalus Life Sciences Inc | Bryan F. Cox | CHIEF OF RESEARCH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | Jennifer Stevens | CHIEF REGULATORY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | Jodi Devlin | Chief of COMMERC. OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Jan 2025 | 63,035 | 63,035 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Jan 2025 | 63,035 | 31,164,205 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Jan 2025 | 63,035 | 63,035 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Jan 2025 | 63,035 | 31,164,205 | - | - | Class B Common Stock | ||
| Processa Pharma Inc | David Young | Director, Pres. Research & Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 62,250 | 62,250 | - | - | Warrants | |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.36 per share. | 27 Jan 2025 | 60,452 | 5,961 (0%) | 0% | 30.4 | 1,835,323 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.36 per share. | 27 Jan 2025 | 60,452 | 5,961 (0%) | 0% | 30.4 | 1,835,323 | Class A Common Stock |
| Texas Instruments | Hagop H. Kozanian | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 56,574 | 56,574 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments | Amichai Ron | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 56,574 | 56,574 | - | - | NQ Stock Option (Right to Buy) | |
| SIGA Tech Inc | Diem Nguyen | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 55,902 | 91,297 (0%) | 0% | 0 | Common Stock, par value $.0001 per share | |
| SIGA Tech Inc | Diem Nguyen | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 55,902 | 111,805 | - | - | Restricted Stock Units | |
| Weave Comm Inc | Brett White T. | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.86 per share. | 27 Jan 2025 | 54,778 | 1,928,364 | - | 15.9 | 868,779 | Common Stock |
| Texas Instruments | Rafael R. Lizardi | Sr. Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 53,246 | 53,246 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments | Mark T. Roberts | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 53,246 | 53,246 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments | Mohammad Yunus | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 53,246 | 53,246 | - | - | NQ Stock Option (Right to Buy) | |
| Alnylam Pharma Inc | Pushkal P. Garg | CMO & EVP Dev & Med Affairs | Sale of securities on an exchange or to another person at price $ 285.00 per share. | 27 Jan 2025 | 52,592 | 11,989 (0%) | 0% | 285 | 14,988,720 | Common Stock |
| American Airlines Grp Inc | Angela Owens K. | SVP Corporate Controller | Sale of securities on an exchange or to another person at price $ 17.15 per share. | 27 Jan 2025 | 51,906 | 112,412 (0%) | 0% | 17.2 | 890,312 | Common Stock |
| JFrog Ltd | Tali Notman | CHIEF REVENUE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 50,635 | 29,201 | - | - | Employee Share Option (right to buy) | |
| JFrog Ltd | Tali Notman | CHIEF REVENUE OFFICER | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 27 Jan 2025 | 50,635 | 582,394 | - | 35 | 1,772,225 | Ordinary Shares |
| JFrog Ltd | Tali Notman | CHIEF REVENUE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.00 per share. | 27 Jan 2025 | 50,635 | 633,029 | - | 23 | 1,164,605 | Ordinary Shares |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.71 per share. | 27 Jan 2025 | 50,066 | 12,969 (0%) | 0% | 30.7 | 1,537,527 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.71 per share. | 27 Jan 2025 | 50,066 | 12,969 (0%) | 0% | 30.7 | 1,537,527 | Class A Common Stock |
| Texas Instruments | Haviv Ilan | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 48,121 | 173,807 (0%) | 0% | 0 | Common Stock | |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 46,983 | 777,714 | - | - | Option (Right to Buy) | |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.26 per share. | 27 Jan 2025 | 46,983 | 84,983 | - | 9.3 | 435,063 | Ordinary Shares |
| Crane Holdings Co. | Max H. Mitchell | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 46,313 | 408,987 (0%) | 0% | 0 | Common Stock | |
| OnKure Therapeutics Inc (Class A) | Samuel Agresta | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 45,000 | 45,000 | - | - | Employee Stock Option (right to buy) | |
| OnKure Therapeutics Inc (Class A) | Dylan Hartley | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 45,000 | 45,000 | - | - | Employee Stock Option (right to buy) | |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Jan 2025 | 44,962 | 44,962 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Jan 2025 | 44,962 | 31,227,240 | - | - | Class B Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Jan 2025 | 44,962 | 44,962 (0%) | 0% | 0 | Class A Common Stock | ||
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 27 Jan 2025 | 44,962 | 31,227,240 | - | - | Class B Common Stock | ||
| Texas Instruments | Mark Gary | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 44,372 | 44,372 | - | - | NQ Stock Option (Right to Buy) | |
| Processa Pharma Inc | Patrick Lin | Chief Business - Strategy Off | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 27 Jan 2025 | 43,500 | 43,500 | - | 0.8 | 34,691 | Common Stock |
| PPL | Vincent Sorgi | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.51 per share. | 27 Jan 2025 | 41,850 | 348,850 (0%) | 0% | 33.5 | 1,402,415 | Common Stock |
| PPL | Vincent Sorgi | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 41,850 | 0 | - | - | Stock Unit (SIP) | |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.86 per share. | 27 Jan 2025 | 40,036 | 4,926 (0%) | 0% | 30.9 | 1,235,511 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.86 per share. | 27 Jan 2025 | 40,036 | 4,926 (0%) | 0% | 30.9 | 1,235,511 | Class A Common Stock |
| TriSalus Life Sciences Inc | Mary T. Szela | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 40,000 | 424,677 | - | 0 | Common Stock | |
| Exlservice Hldgs Inc | Vikas Bhalla | President & Head of Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 39,130 | 157,869 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Franklin BSP Realty Trust Inc | Richard J. Byrne | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.44 per share. | 27 Jan 2025 | 38,975 | 451,091 | - | 12.4 | 484,849 | Common Stock |
| Sera Prognostics Inc (Class A) | Mansoor Raza Mirza | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.91 per share. | 27 Jan 2025 | 37,549 | 44,085 | - | 0.9 | 34,170 | Class A Common Stock |
| Sera Prognostics Inc (Class A) | Mansoor Raza Mirza | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 37,549 | 0 | - | - | Stock Option (right to buy) | |
| QuantumScape Corp (Class A) | Kevin Hettrich | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share. | 27 Jan 2025 | 36,949 | 1,061,274 | - | 2.4 | 87,828 | Class A Common Stock |
| QuantumScape Corp (Class A) | Kevin Hettrich | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.06 per share. | 27 Jan 2025 | 36,949 | 1,024,325 | - | 5.1 | 186,833 | Class A Common Stock |
| QuantumScape Corp (Class A) | Kevin Hettrich | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 36,949 | 229,139 | - | - | Stock Option (Right to Buy) | |
| Rithm Cap Corp | Nicola Santoro | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 36,648 | 36,648 | - | - | Class B Profits Units of Rithm Capital Management LLC | |
| Exlservice Hldgs Inc | Vivek Jetley | President & Head of Analytics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 36,360 | 394,880 (1%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| WisdomTree Inc | Peter M. Ziemba | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 35,154 | 972,752 (0%) | 0% | 0 | Common Stock | |
| WisdomTree Inc | Peter M. Ziemba | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 35,154 | 0 | - | - | Performance Based Restricted Stock Units | |
| Pitney Bowes Inc | Deborah Pfeiffer | EVP & Pres, Presort Services | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 27 Jan 2025 | 35,000 | 124,124 (0%) | 0% | 9.0 | 315,732 | Common Stock |
| Exlservice Hldgs Inc | Maurizio Nicolelli | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 34,950 | 208,193 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 34,741 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.84 per share. | 27 Jan 2025 | 34,741 | 216,954 (0%) | 0% | 74.8 | 2,600,016 | Ordinary Shares |
| Atara Biotherapeutics Inc | Eric Hyllengren | EVP, CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 34,050 | 57,442 (0%) | 0% | 0 | Common Stock | |
| Coupang Inc (Class A) | Hanseung Kang | Rep Director, Business Mngmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 34,036 | 578,514 | - | 0 | Class A Common Stock | |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Jan 2025 | 33,679 | 51,304 | - | - | Ordinary Shares | |
| Merck & Company | Dean Y. Li | Executive VP & President, MRL | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 32,621 | 79,592 (0%) | 0% | 97.9 | 3,194,901 | Common Stock |
| PAMT Corp | Joseph A. Vitiritto | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 32,500 | 187,218 (3%) | 0% | 0 | Common Stock | |
| Apartment Investment & Management Co. (Class A) | Wesley William Powell | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.93 per share. | 27 Jan 2025 | 30,651 | 563,361 | - | 8.9 | 273,713 | Class A Common Stock |
| Medtronic | Geoffrey S. Martha | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.46 per share. | 27 Jan 2025 | 30,184 | 186,770 (0%) | 0% | 92.5 | 2,790,813 | Ordinary Shares |
| Ryan Specialty Holdings Inc (Class A) | Nicholas D. Cortezi | Director | Sale of securities on an exchange or to another person at price $ 65.29 per share. | 27 Jan 2025 | 30,100 | 68,749 | - | 65.3 | 1,965,133 | Class A Common Stock |
| Ryan Specialty Holdings Inc (Class A) | Nicholas D. Cortezi | Director | Sale of securities on an exchange or to another person at price $ 65.08 per share. | 27 Jan 2025 | 30,100 | 38,649 | - | 65.1 | 1,958,923 | Class A Common Stock |
| MSCI | Henry A. Fernandez | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 29,564 | 29,564 | - | - | Option to purchase common stock | |
| Crane Holdings Co. | Max H. Mitchell | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 28,982 | 0 | - | - | 2022 Performance-Based Restricted Share Unit | |
| WisdomTree Inc | Alexis Marinof | Head of Europe | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 28,502 | 0 | - | - | Performance Based Restricted Stock Units | |
| WisdomTree Inc | Alexis Marinof | Head of Europe | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 28,502 | 325,522 (0%) | 0% | 0 | Common Stock | |
| Merck & Company | Chirfi Guindo | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 28,158 | 69,143 (0%) | 0% | 97.9 | 2,757,795 | Common Stock |
| Merck & Company | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 28,136 | 78,758 (0%) | 0% | 97.9 | 2,755,640 | Common Stock |
| Texas Instruments | Ahmad Bahai | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 27,733 | 27,733 | - | - | NQ Stock Option (Right to Buy) | |
| Sun Country Airlines Holdings Inc | John Gyurci | Chief Acct. Off. & VP, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.30 per share. | 27 Jan 2025 | 27,482 | 39,100 | - | 5.3 | 145,655 | Common Stock, par value $0.01 per share |
| Sun Country Airlines Holdings Inc | John Gyurci | Chief Acct. Off. & VP, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 27,482 | 53,883 | - | - | Employee Stock Option (Right to Buy) | |
| Sun Country Airlines Holdings Inc | John Gyurci | Chief Acct. Off. & VP, Finance | Sale of securities on an exchange or to another person at price $ 17.09 per share. | 27 Jan 2025 | 27,482 | 11,618 | - | 17.1 | 469,775 | Common Stock, par value $0.01 per share |
| Grindr Inc (Class A) | J. Michael Gearon | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jan 2025 | 26,977 | 668,423 | - | - | Warrants | |
| Exlservice Hldgs Inc | Vikas Bhalla | President & Head of Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 26,090 | 128,915 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Ally Fin Inc | Michael G. Rhodes | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 39.09 per share. | 27 Jan 2025 | 25,634 | 25,634 (0%) | 0% | 39.1 | 1,002,097 | Common Stock |
| WisdomTree Inc | William Bradley Peck | Head of Digital Assets | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 25,610 | 0 | - | - | Performance Based Restricted Stock Units | |
| WisdomTree Inc | William Bradley Peck | Head of Digital Assets | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 25,610 | 234,648 (0%) | 0% | 0 | Common Stock | |
| Merck & Company | Richard R. DeLuca | EVP&Pres, Merck Animal Heallth | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 25,438 | 178,992 (0%) | 0% | 97.9 | 2,491,398 | Common Stock |
| Merck & Company | Jennifer Zachary | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 25,423 | 55,285 (0%) | 0% | 97.9 | 2,489,929 | Common Stock |
| NewAmsterdam Pharma Co NV | Douglas F. Kling | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 25,385 | 296,586 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Douglas F. Kling | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 25,385 | 69,385 | - | - | Ordinary Shares | |
| Alnylam Pharma Inc | Pushkal P. Garg | CMO & EVP Dev & Med Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 25,000 | 0 | - | - | Performance Stock Option 2015 (right to buy) | |
| Alnylam Pharma Inc | Pushkal P. Garg | CMO & EVP Dev & Med Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.95 per share. | 27 Jan 2025 | 25,000 | 64,581 (0%) | 0% | 89.0 | 2,223,750 | Common Stock |
| DHI Grp Inc | Pamela Bilash | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 25,000 | 582,513 (1%) | 0% | 0 | Common Stock | |
| JFrog Ltd | Tali Notman | CHIEF REVENUE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.12 per share. | 27 Jan 2025 | 25,000 | 607,394 | - | 15.1 | 378,000 | Ordinary Shares |
| JFrog Ltd | Tali Notman | CHIEF REVENUE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 25,000 | 3,387 | - | - | Employee Share Option (right to buy) | |
| JFrog Ltd | Tali Notman | CHIEF REVENUE OFFICER | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 27 Jan 2025 | 25,000 | 582,394 | - | 35 | 875,000 | Ordinary Shares |
| WisdomTree Inc | Marci Frankenthaler | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 24,752 | 0 | - | - | Performance Based Restricted Stock Units | |
| WisdomTree Inc | Marci Frankenthaler | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 24,752 | 297,366 (0%) | 0% | 0 | Common Stock | |
| H.B. Fuller Co | John J. Corkrean | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 24,570 | 24,570 | - | - | Employee Stock Option (Right-to-Buy) | |
| Exlservice Hldgs Inc | Vivek Jetley | President & Head of Analytics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 24,240 | 369,034 (1%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| UMB Fin Corp | J. Mariner Kemper | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 24,191 | 281,987 (0%) | 0% | 0 | Common Stock | |
| TriSalus Life Sciences Inc | James Young | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.40 per share. | 27 Jan 2025 | 24,000 | 24,000 | - | 5.4 | 129,600 | Common Stock |
| Alnylam Pharma Inc | Pushkal P. Garg | CMO & EVP Dev & Med Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 23,876 | 0 | - | - | Stock Option (right to buy) | |
| Alnylam Pharma Inc | Pushkal P. Garg | CMO & EVP Dev & Med Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.95 per share. | 27 Jan 2025 | 23,876 | 39,581 (0%) | 0% | 88.9 | 2,123,770 | Common Stock |
| NewAmsterdam Pharma Co NV | Douglas F. Kling | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Jan 2025 | 23,815 | 44,000 | - | - | Ordinary Shares | |
| Exlservice Hldgs Inc | Narasimha Kini | EVP, Emerging Bus Unit Leader | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 23,760 | 185,327 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Exlservice Hldgs Inc | Anita Mahon | EVP & Business Head Healthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 23,760 | 116,401 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| H.B. Fuller Co | Celeste Beeks Mastin | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 23,666 | 23,666 | - | - | Restricted Stock Units | |
| SIGA Tech Inc | Diem Nguyen | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.34 per share. | 27 Jan 2025 | 23,644 | 67,653 (0%) | 0% | 6.3 | 149,903 | Common Stock, par value $.0001 per share |
| Merck & Company | Caroline A. Litchfield | EVP & CFO | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 23,432 | 74,340 (0%) | 0% | 97.9 | 2,294,930 | Common Stock |
| Exlservice Hldgs Inc | Maurizio Nicolelli | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 23,310 | 179,525 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Franklin BSP Realty Trust Inc | Jerome S. Baglien | CFO and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.44 per share. | 27 Jan 2025 | 23,204 | 237,017 | - | 12.4 | 288,658 | Common Stock |
| Franklin BSP Realty Trust Inc | Michael Comparato | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.44 per share. | 27 Jan 2025 | 23,113 | 471,614 | - | 12.4 | 287,526 | Common Stock |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 27 Jan 2025 | 22,946 | 193,341,524 | - | - | Class B Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 27 Jan 2025 | 22,946 | 22,946 (0%) | 0% | 0 | Class A Common Stock | ||
| Apartment Investment & Management Co. (Class A) | H. Lynn C. Stanfield | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.93 per share. | 27 Jan 2025 | 22,581 | 465,286 | - | 8.9 | 201,648 | Class A Common Stock |
| Joby Aviation Inc | Kate DeHoff | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 22,547 | 22,547 | - | - | Restricted Stock Units (RSUs) | |
| Texas Instruments | Shanon J. Leonard | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 22,186 | 22,186 | - | - | NQ Stock Option (Right to Buy) | |
| Crane Holdings Co. | Max H. Mitchell | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.68 per share. | 27 Jan 2025 | 21,462 | 387,525 (0%) | 0% | 161.7 | 3,469,976 | Common Stock |
| Rollins | Gary W. Rollins | Director, Chairman, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 27 Jan 2025 | 21,462 | 5,234,499 (1%) | 0% | 49.5 | 1,062,369 | Common Stock, $1 Par Value |
| Exlservice Hldgs Inc | Ajay Ayyappan | EVP & Gen Counsel/Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 20,980 | 68,344 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| McCormick & Company | Michael R. Smith | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 20,764 | 130,462 (1%) | 0% | 0 | Common Stock - Voting | |
| Weave Comm Inc | Branden Neish | Chief Product &Technology Ofcr | Sale of securities on an exchange or to another person at price $ 15.86 per share. | 27 Jan 2025 | 20,741 | 491,381 | - | 15.9 | 328,952 | Common Stock |
| Core Scientific Inc - Ordinary Shares - New | Todd A. Becker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 20,448 | 329,937 | - | 0 | Common Stock | |
| Core Scientific Inc - Ordinary Shares - New | Jarrod M. Patten | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 20,448 | 320,448 | - | 0 | Common Stock | |
| Core Scientific Inc - Ordinary Shares - New | Jordan Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 20,448 | 244,387 | - | 0 | Common Stock | |
| Core Scientific Inc - Ordinary Shares - New | Jeffrey David Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 20,448 | 195,687 | - | 0 | Common Stock | |
| Core Scientific Inc - Ordinary Shares - New | Eric Stanton Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 20,448 | 215,687 | - | 0 | Common Stock | |
| NewAmsterdam Pharma Co NV | Douglas F. Kling | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Jan 2025 | 20,237 | 49,148 | - | - | Ordinary Shares | |
| Exlservice Hldgs Inc | Vivek Jetley | President & Head of Analytics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.14 per share. | 27 Jan 2025 | 20,108 | 374,772 (1%) | 0% | 49.1 | 988,107 | Common Stock, par value $0.001 per share |
| Texas Instruments | Richard K. Templeton | Director, Chairman | 27 Jan 2025 | 20,051 | 423,902 (0%) | 0% | 0 | Common Stock | ||
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 40.54 per share. | 27 Jan 2025 | 20,000 | 45,675 (0%) | 0% | 40.5 | 810,800 | Common Stock |
| PAMT Corp | Lance K. Stewart | VP of Finance, CFO, Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 20,000 | 33,906 (0%) | 0% | 0 | Common Stock | |
| Texas Instruments | Christine Witzsche | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 19,968 | 19,968 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments | Katharine Kane | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 19,968 | 19,968 | - | - | NQ Stock Option (Right to Buy) | |
| Teledyne Tech | Robert Mehrabian | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Jan 2025 | 19,500 | 150,321 (0%) | 0% | 0 | Common Stock | |
| Phreesia Inc | Chaim Indig | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.18 per share. | 27 Jan 2025 | 18,325 | 1,268,123 (3%) | 0% | 27.2 | 498,161 | Common Stock |
| Gaming and Leisure Properties Inc | Matthew R. Demchyk | SVP, Chief Investment Officer | Sale of securities on an exchange or to another person at price $ 49.40 per share. | 27 Jan 2025 | 17,617 | 54,140 (0%) | 0% | 49.4 | 870,280 | Common Stock |
| WisdomTree Inc | Bryan J. Edmiston | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 16,370 | 0 | - | - | Performance Based Restricted Stock Units | |
| WisdomTree Inc | Bryan J. Edmiston | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 16,370 | 247,140 (0%) | 0% | 0 | Common Stock | |
| MSCI | C.D. Baer Pettit | Director, President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 16,260 | 16,260 | - | - | Option to purchase common stock | |
| Exlservice Hldgs Inc | Narasimha Kini | EVP, Emerging Bus Unit Leader | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 15,840 | 166,636 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Exlservice Hldgs Inc | Anita Mahon | EVP & Business Head Healthcare | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 15,840 | 97,923 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| First Commonwealth Fin Corp | T. Michael Price | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 15,400 | 51,800 | - | - | Restricted Stock Units-Service Based | |
| Exlservice Hldgs Inc | Vikas Bhalla | President & Head of Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.14 per share. | 27 Jan 2025 | 15,261 | 142,608 (0%) | 0% | 49.1 | 749,926 | Common Stock, par value $0.001 per share |
| WisdomTree Inc | Peter M. Ziemba | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Jan 2025 | 15,102 | 957,650 (0%) | 0% | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Sean E. Murphy | Director, Chief Manuf, Strategy&Bus Dev. | Purchase of securities on an exchange or from another person at price $ 5.31 per share. | 27 Jan 2025 | 15,000 | 182,732 | - | 5.3 | 79,650 | Common Stock |
| TriSalus Life Sciences Inc | Sean E. Murphy | Director, Chief Manuf, Strategy&Bus Dev. | Purchase of securities on an exchange or from another person at price $ 5.17 per share. | 27 Jan 2025 | 15,000 | 197,732 | - | 5.2 | 77,550 | Common Stock |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 14,900 | 762,814 | - | - | Option (Right to Buy) | |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.26 per share. | 27 Jan 2025 | 14,900 | 52,900 | - | 9.3 | 137,974 | Ordinary Shares |
| H.B. Fuller Co | Nathan D. Weaver | Exec VP, Business Transform. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 14,844 | 14,844 | - | - | Employee Stock Option (Right-to-Buy) | |
| H.B. Fuller Co | James J. East | Executive Vice President, HHC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 14,844 | 14,844 | - | - | Employee Stock Option (Right-to-Buy) | |
| SentinelOne Inc (Class A) | Richard Smith | President, Prod Tech & Ops | 27 Jan 2025 | 14,583 | 546,042 | - | 9.7 | 142,038 | Class A Common Stock | |
| SentinelOne Inc (Class A) | Richard Smith | President, Prod Tech & Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 14,583 | 14,584 | - | - | Stock Option (right to buy) | |
| SentinelOne Inc (Class A) | Richard Smith | President, Prod Tech & Ops | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 14,583 | 14,583 | - | - | Class B Common Stock | |
| SentinelOne Inc (Class A) | Richard Smith | President, Prod Tech & Ops | 27 Jan 2025 | 14,583 | 0 | - | - | Class B Common Stock | ||
| Rackspace Tech Inc | Mark A. Marino | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.34 per share. | 27 Jan 2025 | 14,458 | 1,915,356 | - | 2.3 | 33,832 | Common Stock |
| McCormick & Company | Jeffery D. Schwartz | Vice President, Gen Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 14,445 | 76,362 (0%) | 0% | 0 | Common Stock - Voting | |
| Exlservice Hldgs Inc | Ajay Ayyappan | EVP & Gen Counsel/Corp. Secy. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 14,000 | 54,986 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| PPL | Vincent Sorgi | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.51 per share. | 27 Jan 2025 | 13,966 | 334,884 (0%) | 0% | 33.5 | 468,001 | Common Stock |
| Exlservice Hldgs Inc | Maurizio Nicolelli | Executive Vice President & CFO | Sale of securities on an exchange or to another person at price $ 49.14 per share. | 27 Jan 2025 | 13,753 | 194,440 (0%) | 0% | 49.1 | 675,822 | Common Stock, par value $0.001 per share |
| Texas Instruments | Hagop H. Kozanian | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 13,635 | 79,569 (0%) | 0% | 0 | Common Stock | |
| Texas Instruments | Amichai Ron | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 13,635 | 76,936 (0%) | 0% | 0 | Common Stock | |
| WisdomTree Inc | Alexis Marinof | Head of Europe | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Jan 2025 | 13,396 | 312,126 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Kim Kelderman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.70 per share. | 27 Jan 2025 | 13,392 | 52,396 (0%) | 0% | 37.7 | 504,878 | Common Stock |
| Bio-Techne | Kim Kelderman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 13,392 | 0 | - | - | Stock Option (Right to Buy) | |
| Fulton Fin Corp | Angela M. Snyder | President | Sale of securities on an exchange or to another person at price $ 20.69 per share. | 27 Jan 2025 | 13,322 | 63,682 (0%) | 0% | 20.7 | 275,635 | $2.50 par value Common Stock |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Jan 2025 | 13,304 | 38,000 | - | - | Ordinary Shares | |
| First Mid Bancshares Inc | Joseph R. Dively | Director, CEO | Grant, award, or other acquisition of securities at price $ 38.96 per share. | 27 Jan 2025 | 13,200 | 109,052 (0%) | 0% | 39.0 | 514,272 | Common Stock |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.29 per share. | 27 Jan 2025 | 12,969 | 0 (0%) | 0% | 31.3 | 405,800 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.29 per share. | 27 Jan 2025 | 12,969 | 0 (0%) | 0% | 31.3 | 405,800 | Class A Common Stock |
| Texas Instruments | Rafael R. Lizardi | Sr. Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,833 | 86,924 (0%) | 0% | 0 | Common Stock | |
| Texas Instruments | Mark T. Roberts | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,833 | 60,202 (0%) | 0% | 0 | Common Stock | |
| Texas Instruments | Mohammad Yunus | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,833 | 41,787 (0%) | 0% | 0 | Common Stock | |
| Apartment Investment & Management Co. (Class A) | Jennifer Johnson A. | EVP, CAO, and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.93 per share. | 27 Jan 2025 | 12,695 | 308,901 | - | 8.9 | 113,366 | Class A Common Stock |
| Jack In The Box Inc | Lance Tucker | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,595 | 12,595 (0%) | 0% | 0 | COMMON STOCK | |
| Jack In The Box Inc | Lance Tucker | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,595 | 25,190 (0%) | 0% | 0 | COMMON STOCK | |
| Hexcel Corp | Patrick J. Winterlich | EVP, CFO | 27 Jan 2025 | 12,515 | 12,515 | - | - | Non-Qualified Stock Options | ||
| TriSalus Life Sciences Inc | Sean E. Murphy | Director, Chief Manuf, Strategy&Bus Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,500 | 63,288 | - | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Richard Marshak | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,500 | 46,626 | - | 0 | Common Stock | |
| TriSalus Life Sciences Inc | James Young | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,500 | 21,726 | - | 0 | Common Stock | |
| Processa Pharma Inc | Justin W. Yorke | Director | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 27 Jan 2025 | 12,400 | 12,400 | - | 0.8 | 9,889 | Common Stock |
| Processa Pharma Inc | Justin W. Yorke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 12,400 | 12,400 | - | - | Warrants | |
| SentinelOne Inc (Class A) | Richard Smith | President, Prod Tech & Ops | Sale of securities on an exchange or to another person at price $ 23.21 per share. | 27 Jan 2025 | 12,154 | 533,888 | - | 23.2 | 282,037 | Class A Common Stock |
| Adamas Trust Inc | Jason T. Serrano | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.05 per share. | 27 Jan 2025 | 11,841 | 320,828 (0%) | 0% | 6.0 | 71,638 | Common Stock, par value $0.01 per share |
| PPL | Joseph P. Bergstein | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.51 per share. | 27 Jan 2025 | 11,804 | 109,414 (0%) | 0% | 33.5 | 395,582 | Common Stock |
| PPL | Joseph P. Bergstein | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 11,804 | 0 | - | - | Stock Unit (SIP) | |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 55.31 per share. | 27 Jan 2025 | 11,744 | 8,239,347 | - | 55.3 | 649,608 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Gregory M. Weinhoff | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 16.47 per share. | 27 Jan 2025 | 11,742 | 159,782 | - | 16.5 | 193,429 | Ordinary Shares |
| Bio-Techne | Kim Kelderman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 77.19 per share. | 27 Jan 2025 | 11,731 | 40,665 (0%) | 0% | 77.2 | 905,533 | Common Stock |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Jan 2025 | 11,495 | 41,405 | - | - | Ordinary Shares | |
| Exlservice Hldgs Inc | Anita Mahon | EVP & Business Head Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.14 per share. | 27 Jan 2025 | 11,400 | 105,001 (0%) | 0% | 49.1 | 560,196 | Common Stock, par value $0.001 per share |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | 27 Jan 2025 | 11,195 | 8,463,087 | - | - | Class B Common Stock | ||
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | 27 Jan 2025 | 11,195 | 390,888 (0%) | 0% | 0 | Class A Common Stock | ||
| Exlservice Hldgs Inc | Ajay Ayyappan | EVP & Gen Counsel/Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.14 per share. | 27 Jan 2025 | 11,172 | 57,172 (0%) | 0% | 49.1 | 548,992 | Common Stock, par value $0.001 per share |
| WisdomTree Inc | William Bradley Peck | Head of Digital Assets | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Jan 2025 | 11,079 | 223,569 (0%) | 0% | 0 | Common Stock | |
| H.B. Fuller Co | Heather A. Campe | Sr. VP, International Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 10,831 | 10,831 | - | - | Employee Stock Option (Right-to-Buy) | |
| Texas Instruments | Mark Gary | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 10,694 | 48,620 (0%) | 0% | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Bryan F. Cox | CHIEF OF RESEARCH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 10,625 | 97,007 | - | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Jennifer Stevens | CHIEF REGULATORY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 10,625 | 43,408 | - | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Jodi Devlin | Chief of COMMERC. OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 10,625 | 28,125 | - | 0 | Common Stock | |
| Exlservice Hldgs Inc | Vivek Jetley | President & Head of Analytics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.14 per share. | 27 Jan 2025 | 10,514 | 358,520 (1%) | 0% | 49.1 | 516,658 | Common Stock, par value $0.001 per share |
| Exlservice Hldgs Inc | Narasimha Kini | EVP, Emerging Bus Unit Leader | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.14 per share. | 27 Jan 2025 | 10,334 | 174,993 (0%) | 0% | 49.1 | 507,813 | Common Stock, par value $0.001 per share |
| Merck & Company | David Michael Williams | EVP,Chief Info&Digital Officer | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 10,246 | 30,123 (0%) | 0% | 97.9 | 1,003,493 | Common Stock |
| H.B. Fuller Co | Gregory O. Ogunsanya | Sr. VP, GC and Corp Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 10,237 | 10,237 | - | - | Employee Stock Option (Right-to-Buy) | |
| H.B. Fuller Co | Laura J. Lorenz | Sr. VP, HR & Communication | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 10,237 | 10,237 | - | - | Employee Stock Option (Right-to-Buy) | |
| Crane Holdings Co. | Richard A. Maue | Exec. V.P & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 10,211 | 86,914 (0%) | 0% | 0 | Common Stock | |
| Exlservice Hldgs Inc | Vikas Bhalla | President & Head of Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.14 per share. | 27 Jan 2025 | 10,176 | 118,739 (0%) | 0% | 49.1 | 500,049 | Common Stock, par value $0.001 per share |
| Braze Inc (Class A) | Susan Wiseman | General Counsel | Sale of securities on an exchange or to another person at price $ 47.22 per share. | 27 Jan 2025 | 10,000 | 189,520 | - | 47.2 | 472,200 | Class A Common Stock |
| WisdomTree Inc | Marci Frankenthaler | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Jan 2025 | 9,681 | 287,685 (0%) | 0% | 0 | Common Stock | |
| Adamas Trust Inc | Steven R. Mumma | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.05 per share. | 27 Jan 2025 | 9,628 | 491,541 (0%) | 0% | 6.0 | 58,249 | Common Stock, par value $0.01 per share |
| Minerals Tech Inc | Douglas T. Dietrich | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 9,549 | 164,956 (0%) | 0% | 0 | Common Stock | |
| Minerals Tech Inc | Douglas T. Dietrich | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 9,549 | 63,253 | - | - | Deferred Restricted Stock Units (DRSUs) | |
| Merck & Company | Cristal N. Downing | Chief Comm. & Public Afrs Ofcr | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 9,446 | 9,446 (0%) | 0% | 97.9 | 925,141 | Common Stock |
| UMB Fin Corp | J. Mariner Kemper | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.11 per share. | 27 Jan 2025 | 9,430 | 272,557 (0%) | 0% | 121.1 | 1,142,067 | Common Stock |
| QCR Holding Inc | Todd A. Gipple | Director, President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 8,857 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| QCR Holding Inc | Todd A. Gipple | Director, President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.49 per share. | 27 Jan 2025 | 8,857 | 48,900 (0%) | 0% | 17.5 | 154,909 | Common Stock |
| Merck & Company | Jannie Oosthuizen | President, U.S. Market | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 8,664 | 32,607 (0%) | 0% | 97.9 | 848,552 | Common Stock |
| Hexcel Corp | Gail E. Lehman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 8,661 | 8,661 | - | - | Non-Qualified Stock Options | |
| Rollins | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 27 Jan 2025 | 8,372 | 666,797 (0%) | 0% | 49.5 | 414,414 | Common Stock |
| PPL | Wendy E. Stark | EVP & CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 8,323 | 0 | - | - | Stock Unit (SIP) | |
| PPL | Wendy E. Stark | EVP & CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.51 per share. | 27 Jan 2025 | 8,323 | 28,697 (0%) | 0% | 33.5 | 278,931 | Common Stock |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 53.52 per share. | 27 Jan 2025 | 8,296 | 8,258,291 | - | 53.5 | 444,008 | Ordinary Shares |
| Phreesia Inc | David Linetsky | SVP, Life Sciences | Sale of securities on an exchange or to another person at price $ 27.18 per share. | 27 Jan 2025 | 8,158 | 234,798 (0%) | 0% | 27.2 | 221,774 | Common Stock |
| Las Vegas Sands | Mark M. Besca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 8,136 | 8,136 | - | - | Common Stock (Right to Buy) | |
| Pro-Dex Inc (co) | Raymond E. Cabillot | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 41.62 per share. | 27 Jan 2025 | 8,077 | 325,133 (8%) | 0% | 41.6 | 336,165 | Common Stock |
| First Commonwealth Fin Corp | Jane Grebenc | Director, EVP/Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 8,000 | 30,900 | - | - | Restricted Stock Units-Service Based | |
| Phreesia Inc | Chaim Indig | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.15 per share. | 27 Jan 2025 | 7,923 | 1,260,200 (3%) | 0% | 28.2 | 223,036 | Common Stock |
| Zynex Inc | Anna Lucsok | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.19 per share. | 27 Jan 2025 | 7,911 | 33,820 (0%) | 0% | 8.2 | 64,791 | Common Stock |
| Corcept Therapeutics Inc | James N. Wilson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Jan 2025 | 7,800 | 1,445,168 (1%) | 0% | 0 | Common Stock | |
| Adamas Trust Inc | Nicholas Mah | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.05 per share. | 27 Jan 2025 | 7,684 | 207,007 (0%) | 0% | 6.0 | 46,488 | Common Stock, par value $0.01 per share |
| H.B. Fuller Co | Xinyu Du | Sr. VP, Global R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 7,678 | 7,678 | - | - | Employee Stock Option (Right-to-Buy) | |
| Energy Recovery Inc | David W. Moon | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.40 per share. | 27 Jan 2025 | 7,664 | 168,417 (0%) | 0% | 14.4 | 110,362 | Common Stock |
| Exlservice Hldgs Inc | Ajay Ayyappan | EVP & Gen Counsel/Corp. Secy. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.14 per share. | 27 Jan 2025 | 7,622 | 47,364 (0%) | 0% | 49.1 | 374,545 | Common Stock, par value $0.001 per share |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 111.00 per share. | 27 Jan 2025 | 7,500 | 7,500 (0%) | 0% | 111 | 832,500 | Common Stock |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 7,500 | 37,179 | - | - | Stock Options | |
| Zynex Inc | Anna Lucsok | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 7,500 | 62,956 | - | 0 | Common Stock (Restricted Stock Award) | |
| Phreesia Inc | Evan Roberts | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 27.18 per share. | 27 Jan 2025 | 7,481 | 767,542 (2%) | 0% | 27.2 | 203,369 | Common Stock |
| H.B. Fuller Co | Zhiwei Cai | Executive Vice President, EA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 7,422 | 7,422 | - | - | Employee Stock Option (Right-to-Buy) | |
| MACOM Tech Soln Holdings Inc | Dong Hyun Hwang | SVP, Global Sales | Sale of securities on an exchange or to another person at price $ 133.00 per share. | 27 Jan 2025 | 7,355 | 43,657 (0%) | 0% | 133 | 978,215 | Common Stock |
| First Commonwealth Fin Corp | James R. Reske | EVP/Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 7,300 | 27,900 | - | - | Restricted Stock Units-Service Based | |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 54.43 per share. | 27 Jan 2025 | 7,200 | 8,251,091 | - | 54.4 | 391,909 | Ordinary Shares |
| Kratos Defense & Security Soln Inc | Steven Fendley | President, US Division | Sale of securities on an exchange or to another person at price $ 33.16 per share. | 27 Jan 2025 | 7,000 | 365,461 (0%) | 0% | 33.2 | 232,092 | Common Stock |
| First Commonwealth Fin Corp | Michael P. McCuen | EVP/Chief Lending Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 6,900 | 13,700 | - | - | Common Stock | |
| 3M | Kevin H. Rhodes | EVP, Chief Legal Off & Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.05 per share. | 27 Jan 2025 | 6,850 | 11,645 (0%) | 0% | 146.1 | 1,000,443 | Common Stock |
| 3M | Kevin H. Rhodes | EVP, Chief Legal Off & Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 6,850 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Margaret Alexander | President and COO | Purchase of securities on an exchange or from another person at price $ 0.73 per share. | 27 Jan 2025 | 6,810 | 34,935 (0%) | 0% | 0.7 | 4,971 | Common Stock |
| Innovative Soln And Support Inc | Denise L. Devine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 6,781 | 6,781 | - | 0 | Restricted Stock Units | |
| 3M | Kevin H. Rhodes | EVP, Chief Legal Off & Secret | Sale of securities on an exchange or to another person at price $ 149.85 per share. | 27 Jan 2025 | 6,743 | 4,902 (0%) | 0% | 149.8 | 1,010,416 | Common Stock |
| UMB Fin Corp | James D. Rine | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 6,729 | 45,391 (0%) | 0% | 0 | Common Stock | |
| Texas Instruments | Ahmad Bahai | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 6,684 | 41,764 (0%) | 0% | 0 | Common Stock | |
| WisdomTree Inc | Bryan J. Edmiston | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Jan 2025 | 6,666 | 240,474 (0%) | 0% | 0 | Common Stock | |
| Hexcel Corp | Thierry Merlot | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 6,511 | 6,511 | - | - | Non-Qualified Stock Options | |
| Crane Holdings Co. | Richard A. Maue | Exec. V.P & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 6,390 | 0 | - | - | 2022 Performance-Based Restricted Share Unit | |
| Crane Holdings Co. | Anthony M. D'Iorio | Exec. V.P., Gen. Couns. & Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 6,283 | 32,270 (0%) | 0% | 0 | Common Stock | |
| Exlservice Hldgs Inc | Maurizio Nicolelli | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.14 per share. | 27 Jan 2025 | 6,282 | 173,243 (0%) | 0% | 49.1 | 308,697 | Common Stock, par value $0.001 per share |
| Phreesia Inc | Allison Hoffman | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 28.50 per share. | 27 Jan 2025 | 6,235 | 146,126 (0%) | 0% | 28.5 | 177,698 | Common Stock |
| Processa Pharma Inc | Justin W. Yorke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 6,200 | 6,200 | - | - | Warrants | |
| PPL | John R. Crockett | President of a PPL Subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 5,910 | 0 | - | - | Stock Unit (SIP) | |
| PPL | John R. Crockett | President of a PPL Subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.51 per share. | 27 Jan 2025 | 5,910 | 16,755 (0%) | 0% | 33.5 | 198,070 | Common Stock |
| Robinhood Markets Inc (Class A) | Jeffrey Pinner | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 47.82 per share. | 27 Jan 2025 | 5,876 | 0 | - | 47.8 | 280,963 | Class A Common Stock |
| Leslies Inc | Moyo Labode | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 5,814 | 70,266 | - | 0 | Common Stock, par value $0.001 per share | |
| Leslies Inc | Moyo Labode | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 5,814 | 171,913 | - | - | Restricted Stock Units | |
| Energy Recovery Inc | Rodney Clemente | SVP, Water | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.40 per share. | 27 Jan 2025 | 5,784 | 134,806 (0%) | 0% | 14.4 | 83,290 | Common Stock |
| First Commonwealth Fin Corp | Norman J. Montgomery | EVP/Business Integration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 5,750 | 23,050 | - | - | Restricted Stock Units-Service Based | |
| Energy Recovery Inc | Farshad Ghasripoor | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.40 per share. | 27 Jan 2025 | 5,721 | 121,240 (0%) | 0% | 14.4 | 82,382 | Common Stock |
| First Commonwealth Fin Corp | Matthew C. Tomb | EVP/Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 5,700 | 22,800 | - | - | Restricted Stock Units-Service Based | |
| Intrepid Potash Inc | Robert P. Jornayvaz | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.35 per share. | 27 Jan 2025 | 5,600 | 99,063 (0%) | 0% | 27.4 | 153,160 | Common Stock |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.66 per share. | 27 Jan 2025 | 5,581 | 380 (0%) | 0% | 31.7 | 176,694 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.66 per share. | 27 Jan 2025 | 5,581 | 380 (0%) | 0% | 31.7 | 176,694 | Class A Common Stock |
| Texas Instruments | Julie Knecht | VP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 5,547 | 5,547 | - | - | NQ Stock Option (Right to Buy) | |
| Crane Holdings Co. | Alejandro A. Alcala | Exec. V.P. & Chief Op. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 5,499 | 34,904 (0%) | 0% | 0 | Common Stock | |
| Pro-Dex Inc (co) | Raymond E. Cabillot | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 41.64 per share. | 27 Jan 2025 | 5,381 | 319,752 (8%) | 0% | 41.6 | 224,065 | Common Stock |
| Texas Instruments | Shanon J. Leonard | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 5,347 | 29,513 (0%) | 0% | 0 | Common Stock | |
| Exlservice Hldgs Inc | Anita Mahon | EVP & Business Head Healthcare | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.14 per share. | 27 Jan 2025 | 5,282 | 92,641 (0%) | 0% | 49.1 | 259,557 | Common Stock, par value $0.001 per share |
| Minerals Tech Inc | Douglas T. Dietrich | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.19 per share. | 27 Jan 2025 | 5,281 | 159,675 (0%) | 0% | 76.2 | 402,359 | Common Stock |
| Public Storage | Ronald P. Spogli | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 5,163 | 0 | - | - | AO LTIP Units | |
| First Commonwealth Fin Corp | Brian Sohocki | EVP/Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 5,150 | 5,150 | - | - | Restricted Stock Units-Service Based | |
| NewAmsterdam Pharma Co NV | Douglas F. Kling | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Jan 2025 | 5,148 | 44,000 | - | - | Ordinary Shares | |
| Exlservice Hldgs Inc | Narasimha Kini | EVP, Emerging Bus Unit Leader | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.14 per share. | 27 Jan 2025 | 5,069 | 161,567 (0%) | 0% | 49.1 | 249,091 | Common Stock, par value $0.001 per share |
| ReposiTrak | Randall K. Fields | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.95 per share. | 27 Jan 2025 | 5,000 | 319,500 (1%) | 0% | 20.9 | 104,736 | Common Stock |
| Conmed Corp | Andrew James Moller | VP Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 5,000 | 5,000 | - | - | Options To Purchase Common Stock | |
| Patrick Ind Inc | Andy L. Nemeth | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.50 per share. | 27 Jan 2025 | 4,956 | 358,223 (1%) | 0% | 97.5 | 483,210 | Common Stock |
| Revolve Grp Inc (Class A) | Michael Karanikolas | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.50 per share. | 27 Jan 2025 | 4,926 | 0 (0%) | 0% | 31.5 | 155,169 | Class A Common Stock |
| Revolve Grp Inc (Class A) | Michael Mente | Director, CO-CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.50 per share. | 27 Jan 2025 | 4,926 | 0 (0%) | 0% | 31.5 | 155,169 | Class A Common Stock |
| Ryan Specialty Holdings Inc (Class A) | Nicholas D. Cortezi | Director | Sale of securities on an exchange or to another person at price $ 65.03 per share. | 27 Jan 2025 | 4,900 | 1,309 | - | 65.0 | 318,661 | Class A Common Stock |
| Ryan Specialty Holdings Inc (Class A) | Nicholas D. Cortezi | Director | Sale of securities on an exchange or to another person at price $ 65.02 per share. | 27 Jan 2025 | 4,900 | 6,209 | - | 65.0 | 318,612 | Class A Common Stock |
| Hexcel Corp | Patrick J. Winterlich | EVP, CFO | 27 Jan 2025 | 4,897 | 4,897 | - | - | Restricted Stock Units | ||
| TriSalus Life Sciences Inc | Mary T. Szela | Director, CEO AND PRESIDENT | Purchase of securities on an exchange or from another person at price $ 5.42 per share. | 27 Jan 2025 | 4,826 | 429,503 | - | 5.4 | 26,157 | Common Stock |
| Texas Instruments | Christine Witzsche | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 4,813 | 22,290 (0%) | 0% | 0 | Common Stock | |
| Texas Instruments | Katharine Kane | SVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 4,813 | 21,627 (0%) | 0% | 0 | Common Stock | |
| 3M | John Patrick Banovetz | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.05 per share. | 27 Jan 2025 | 4,798 | 31,346 (0%) | 0% | 146.1 | 700,748 | Common Stock |
| 3M | John Patrick Banovetz | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 4,798 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| 3M | John Patrick Banovetz | Executive Vice President | Sale of securities on an exchange or to another person at price $ 151.36 per share. | 27 Jan 2025 | 4,798 | 26,548 (0%) | 0% | 151.4 | 726,249 | Common Stock |
| TeraWulf Inc | Michael C. Bucella | Director | Purchase of securities on an exchange or from another person at price $ 4.17 per share. | 27 Jan 2025 | 4,796 | 205,632 | - | 4.2 | 19,999 | Common stock, $0.001 par value per share |
| Crane Holdings Co. | Richard A. Maue | Exec. V.P & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.68 per share. | 27 Jan 2025 | 4,732 | 82,182 (0%) | 0% | 161.7 | 765,070 | Common Stock |
| TriSalus Life Sciences Inc | Mary T. Szela | Director, CEO AND PRESIDENT | Purchase of securities on an exchange or from another person at price $ 5.12 per share. | 27 Jan 2025 | 4,716 | 434,219 | - | 5.1 | 24,146 | Common Stock |
| Crane Holdings Co. | Tamara S. Polmanteer | Exec. Vice President & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 4,713 | 7,420 (0%) | 0% | 0 | Common Stock | |
| Hexcel Corp | Gina Fitzsimons | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 4,710 | 4,710 | - | - | Non-Qualified Stock Options | |
| H.B. Fuller Co | Robert J. Martsching | VP, Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 4,606 | 4,606 | - | - | Employee Stock Option (Right-to-Buy) | |
| ServisFirst Bancshares Inc | Thomas A. Broughton | Director, Chairman, President, & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 4,596 | 28,430 (0%) | 0% | 0 | Common Stock | |
| Phreesia Inc | Allison Hoffman | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 27.18 per share. | 27 Jan 2025 | 4,577 | 154,340 (0%) | 0% | 27.2 | 124,425 | Common Stock |
| ServisFirst Bancshares Inc | Thomas A. Broughton | Director, Chairman, President, & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 4,569 | 284,375 (0%) | 0% | 0 | Common Stock | |
| Rollins | Jerry E. Gahlhoff | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 27 Jan 2025 | 4,460 | 283,267 (0%) | 0% | 49.5 | 220,770 | Common Stock |
| Coastal Fin Corp | Sprink M Eric | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.38 per share. | 27 Jan 2025 | 4,318 | 232,070 (1%) | 0% | 84.4 | 364,353 | Common Stock |
| H.B. Fuller Co | John J. Corkrean | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 4,302 | 4,302 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Michael Benkowitz | PRESIDENT AND COO | Sale of securities on an exchange or to another person at price $ 369.54 per share. | 27 Jan 2025 | 4,147 | 3,353 (0%) | 0% | 369.5 | 1,532,482 | Common Stock |
| Marinemax Inc | Clint Moore | Director | Sale of securities on an exchange or to another person at price $ 30.63 per share. | 27 Jan 2025 | 4,100 | 23,560 (0%) | 0% | 30.6 | 125,583 | Common Stock |
| McCormick & Company | Andrew Foust | President, Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 4,063 | 9,411 (0%) | 0% | 0 | Common Stock - Voting | |
| Energy Recovery Inc | William Yeung W. | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.40 per share. | 27 Jan 2025 | 4,061 | 105,186 (0%) | 0% | 14.4 | 58,478 | Common Stock |
| First Commonwealth Fin Corp | Carrie L. Riggle | EVP/Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 4,050 | 14,050 | - | - | Restricted Stock Units-Service Based | |
| Axalta Coating Systems Ltd | Timothy E. Bowes | President, Glbl Ind. Coatings | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 4,034 | 4,034 | - | - | Restricted Stock Units | |
| Marinemax Inc | Anthony E. Cassella | EVP of Finance & CAO | Sale of securities on an exchange or to another person at price $ 31.06 per share. | 27 Jan 2025 | 4,000 | 11,451 (0%) | 0% | 31.1 | 124,240 | Common Stock |
| QCR Holding Inc | Todd A. Gipple | Director, President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.93 per share. | 27 Jan 2025 | 3,998 | 44,902 (0%) | 0% | 78.9 | 315,562 | Common Stock |
| Wintrust Fin Corp | Edward J. Wehmer | Director, FOUNDER AND SENIOR ADVISOR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.46 per share. | 27 Jan 2025 | 3,965 | 192,460 (0%) | 0% | 131.5 | 521,239 | Common Stock |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 59.12 per share. | 27 Jan 2025 | 3,954 | 8,231,979 | - | 59.1 | 233,762 | Ordinary Shares |
| Crane Holdings Co. | Anthony M. D'Iorio | Exec. V.P., Gen. Couns. & Sec. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,932 | 0 | - | - | 2022 Performance-Based Restricted Share Unit | |
| TE Connectivity | Shadrak W. Kroeger | Pres., Industrial Solutions | Sale of securities on an exchange or to another person at price $ 151.16 per share. | 27 Jan 2025 | 3,888 | 25,976 (0%) | 0% | 151.2 | 587,706 | Common Shares |
| Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,883 | 3,884 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Ilan Ganot | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,883 | 98,690 (0%) | 0% | - | Common Stock | |
| First Mid Bancshares Inc | Michael L. Taylor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 38.96 per share. | 27 Jan 2025 | 3,850 | 31,045 (0%) | 0% | 39.0 | 149,996 | Common Stock |
| First Mid Bancshares Inc | Eric S. McRae | EVP, Chief Lending Officer | Grant, award, or other acquisition of securities at price $ 38.96 per share. | 27 Jan 2025 | 3,850 | 31,571 (0%) | 0% | 39.0 | 149,996 | Common Stock |
| First Mid Bancshares Inc | Matthew K. Smith | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 38.96 per share. | 27 Jan 2025 | 3,850 | 17,746 (0%) | 0% | 39.0 | 149,996 | Common Stock |
| PPL | Angela K. Gosman | EVP and CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.52 per share. | 27 Jan 2025 | 3,845 | 16,722 (0%) | 0% | 33.5 | 128,866 | Common Stock |
| PPL | Angela K. Gosman | EVP and CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,845 | 0 | - | - | Stock Unit (SIP) | |
| Union Pacific | Craig V. Richardson | EVP CHIEF LEGAL OFFICER & CORP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 186.11 per share. | 27 Jan 2025 | 3,729 | 30,048 (0%) | 0% | 186.1 | 694,004 | Common Stock |
| Union Pacific | Craig V. Richardson | EVP CHIEF LEGAL OFFICER & CORP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,729 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Union Pacific | Craig V. Richardson | EVP CHIEF LEGAL OFFICER & CORP | Sale of securities on an exchange or to another person at price $ 252.00 per share. | 27 Jan 2025 | 3,729 | 26,319 (0%) | 0% | 252 | 939,708 | Common Stock |
| 3M | Zoe L. Dickson | EVP & Chief HR Officer | Sale of securities on an exchange or to another person at price $ 149.41 per share. | 27 Jan 2025 | 3,634 | 4,461 (0%) | 0% | 149.4 | 542,957 | Common Stock |
| 3M | Zoe L. Dickson | EVP & Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,634 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| 3M | Zoe L. Dickson | EVP & Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.05 per share. | 27 Jan 2025 | 3,634 | 8,095 (0%) | 0% | 146.1 | 530,746 | Common Stock |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 63.21 per share. | 27 Jan 2025 | 3,600 | 8,221,221 | - | 63.2 | 227,567 | Ordinary Shares |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 59.97 per share. | 27 Jan 2025 | 3,600 | 8,228,379 | - | 60.0 | 215,887 | Ordinary Shares |
| PPL | Joseph P. Bergstein | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.51 per share. | 27 Jan 2025 | 3,585 | 105,829 (0%) | 0% | 33.5 | 120,133 | Common Stock |
| Phreesia Inc | David Linetsky | SVP, Life Sciences | Sale of securities on an exchange or to another person at price $ 28.15 per share. | 27 Jan 2025 | 3,527 | 231,271 (0%) | 0% | 28.2 | 99,287 | Common Stock |
| Alcoa Corp | Tammi A. Jones | EVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.97 per share. | 27 Jan 2025 | 3,493 | 34,142 (0%) | 0% | 35.0 | 122,150 | Common Stock, par value $0.01 per share |
| Crane Holdings Co. | Alejandro A. Alcala | Exec. V.P. & Chief Op. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,441 | 0 | - | - | 2022 Performance-Based Restricted Share Unit | |
| MSCI | Scott A. Crum | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 3,415 | 3,415 | - | - | Option to purchase common stock | |
| NewAmsterdam Pharma Co NV | Ian Somaiya | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Jan 2025 | 3,405 | 38,000 | - | - | Ordinary Shares | |
| Hexcel Corp | Gail E. Lehman | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 3,389 | 3,389 | - | - | Restricted Stock Units | |
| Plexus Corp | Patrick J. Jermain | Exec. VP & CFO | Sale of securities on an exchange or to another person at price $ 144.57 per share. | 27 Jan 2025 | 3,361 | 20,745 (0%) | 0% | 144.6 | 485,886 | Common Stock, $.01 par value |
| Phreesia Inc | Balaji Gandhi | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.18 per share. | 27 Jan 2025 | 3,360 | 146,386 (0%) | 0% | 27.2 | 91,341 | Common Stock |
| Alcoa Corp | William F. Oplinger | Director, President, CEO & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.97 per share. | 27 Jan 2025 | 3,353 | 190,466 (0%) | 0% | 35.0 | 117,254 | Common Stock, par value $0.01 per share |
| Hexcel Corp | Patrick J. Winterlich | EVP, CFO | 27 Jan 2025 | 3,348 | 43,642 (0%) | 0% | 44.0 | 147,178 | Common Stock | |
| Hexcel Corp | Patrick J. Winterlich | EVP, CFO | 27 Jan 2025 | 3,348 | 0 | - | - | Employee Stock Option (Right to Buy) |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.